KVUE vs. ABT
KVUE (Kenvue Inc.) and ABT (Abbott Laboratories) are both stocks. KVUE operates in Household & Personal Products (Consumer Defensive), while ABT operates in Medical Devices (Healthcare). Over the past 3 years, KVUE returned -7.74%/yr vs -3.82%/yr for ABT. At a 0.30 correlation, their price movements are largely independent.
Performance
KVUE vs. ABT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KVUE achieves a 9.24% return, which is significantly higher than ABT's -26.92% return.
KVUE
- 1D
- 3.08%
- 1M
- 5.02%
- YTD
- 9.24%
- 6M
- 10.72%
- 1Y
- -9.85%
- 3Y*
- -7.74%
- 5Y*
- —
- 10Y*
- —
ABT
- 1D
- 3.07%
- 1M
- 3.57%
- YTD
- -26.92%
- 6M
- -26.48%
- 1Y
- -30.68%
- 3Y*
- -3.82%
- 5Y*
- -2.30%
- 10Y*
- 11.16%
KVUE vs. ABT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
KVUE Kenvue Inc. | 9.24% | -15.86% | 3.12% | -14.06% |
ABT Abbott Laboratories | -26.92% | 12.87% | 4.81% | -0.49% |
Correlation
The correlation between KVUE and ABT is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since May 4, 2023 | 0.30 |
Fundamentals
KVUE:
$35.38B
ABT:
$158.16B
KVUE:
$0.84
ABT:
$3.59
KVUE:
21.83
ABT:
25.22
KVUE:
2.32
ABT:
3.51
KVUE:
3.34
ABT:
2.39
KVUE:
$15.29B
ABT:
$45.13B
KVUE:
$8.93B
ABT:
$25.45B
KVUE:
$3.03B
ABT:
$10.80B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KVUE vs. ABT — Risk / Return Rank
KVUE
ABT
KVUE vs. ABT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kenvue Inc. (KVUE) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KVUE | ABT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.93 | ||
| Sortino ratioReturn per unit of downside risk | +1.45 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.78 | +0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.26 | -0.79 | +0.53 |
| Martin ratioReturn relative to average drawdown | -0.48 | -1.66 | +1.18 |
Loading charts...
Drawdowns
KVUE vs. ABT - Drawdown Comparison
The maximum KVUE drawdown since its inception was -44.08%, roughly equal to the maximum ABT drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for KVUE and ABT.
Loading charts...
Drawdown Indicators
| KVUE | ABT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.08% | -45.66% | +1.58% |
Max Drawdown (1Y)Largest decline over 1 year | -37.63% | -38.99% | +1.36% |
Max Drawdown (3Y)Largest decline over 3 years | -41.92% | -39.64% | -2.28% |
Max Drawdown (5Y)Largest decline over 5 years | — | -39.64% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -39.64% | — |
Current DrawdownCurrent decline from peak | -24.37% | -33.81% | +9.44% |
Average DrawdownAverage peak-to-trough decline | -21.05% | -10.86% | -10.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.58% | 18.52% | +2.06% |
Volatility
KVUE vs. ABT - Volatility Comparison
Kenvue Inc. (KVUE) and Abbott Laboratories (ABT) have volatilities of 7.95% and 7.81%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KVUE | ABT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.95% | 7.81% | +0.14% |
Volatility (6M)Calculated over the trailing 6-month period | 14.79% | 19.69% | -4.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.45% | 24.86% | +7.59% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.79% | 22.15% | +6.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.79% | 23.66% | +5.13% |
Dividends
KVUE vs. ABT - Dividend Comparison
KVUE's dividend yield for the trailing twelve months is around 4.51%, more than ABT's 2.70% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.70% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
KVUE Kenvue Inc. | 4.51% | 4.78% | 3.79% | 1.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
KVUE vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Kenvue Inc. and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KVUE vs. ABT - Profitability Comparison
KVUE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kenvue Inc. reported a gross profit of 2.30B and revenue of 3.91B. Therefore, the gross margin over that period was 58.9%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.
KVUE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kenvue Inc. reported an operating income of 767.00M and revenue of 3.91B, resulting in an operating margin of 19.6%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.
KVUE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kenvue Inc. reported a net income of 474.00M and revenue of 3.91B, resulting in a net margin of 12.1%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.
Frequently Asked Questions
KVUE and ABT have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KVUE has higher volatility (7.95%) compared to ABT (7.81%). In terms of maximum drawdown, KVUE dropped -44.08% vs ABT's -45.66%.
KVUE currently has the higher Sharpe Ratio (-0.30 vs -1.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KVUE and ABT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer